YHLO 2025 Global Partner Conference Successfully Held
Amidst the serene beauty of Dameisha’s coastline, the 2025 YHLO Global Partner Conference officially commenced on April 14 in Shenzhen. The event welcomed over 100 representatives and experts from over 40 countries, uniting to chart a shared vision for the future. Centered around the theme “Scale Success with Academic Power,” this conference aimed to provide global partners with cutting-edge ideas and broader perspectives through frontier academic discussions and in-depth cooperation, working together to expand YHLO's brand influence in the international market.
The event began with a keynote address by Mr. Hu Kunhui, Chairman of YHLO Group, who extended a warm welcome to the partners and experts who had traveled from afar. Mr. Hu highlighted, “In the past year, YHLO has achieved significant leaps, successfully launching the iTLA Max total intelligent ecosystem solution, as well as flagship products such as the fully automated biochemistry analyzers iBC 2000 and iBC 900. Our independent innovation capabilities have been greatly enhanced, and our clinical diagnostic technology has reached new heights. Looking ahead, YHLO will continue to adhere to the business strategy of “innovation-driven, quality-first,” increase R&D investment, deepen its global localization strategy, and strengthen support for key international regions and projects. By empowering international distributors, we will realize resource sharing and mutual benefits, and jointly open a new chapter of strategic cooperation with our partners.
During the morning session, Dr. Ming Wang, Global Academic Director, and Mr. Cong Xiao, Deputy Director of International Marketing, presented YHLO's achievements in the market and its notable progress in the international academic field. They emphasized that YHLO will uphold the core marketing concept of “innovation-led, academic-empowered,” making academic strength a powerful tool for market promotion and continuously empowering customers. At the same time, Ms. Yue Yin, General Manager of YHLO's Distribution System, shared firsthand experiences on how strong distributor-brand partnerships can lead to mutual success and long-term growth. Her presentation resonated strongly with attendees. Many attendees expressed that YHLO’s cooperative model is highly trustworthy, and they look forward to working hand-in-hand with YHLO to create greater success in the future. In addition, the product managers of YHLO’s independently developed iTLA Max total laboratory automation system and the iBC 2000 fully automated biochemistry analyzer provided detailed introductions of these two new products to the attendees. These products not only showcased YHLO’s strong independent innovation capabilities but also conveyed brand confidence, further strengthening customers’ recognition and trust in YHLO's products.
In the academic session held in the afternoon, Mr. Richard Li, Director of the International Marketing Center, delivered the opening remarks. The conference was honored to invite distinguished experts from both domestic and international fields, such as cardiac biomarkers, autoimmune diagnostics, neuroscience, and diabetes. These experts shared the latest findings from their research in their respective areas, and emphasized the key role that YHLO plays in these fields, conveying the excellence and reliability of YHLO’s products to the audience. In addition, Prof. Sergio Bernardini, Secretary of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), also gave a detailed presentation on how IFCC, as a major academic organization in global clinical chemistry and laboratory medicine, promotes the collaboration and development of localized academic research. He further acknowledged YHLO’s contribution to the advancement of the IVD industry.
At the end of the conference, attending representatives delivered remarks expressing their recognition of YHLO’s achievements in innovation, and their support for the “innovation-led, academic-empowered” marketing strategy. Partners firmly believed that, under the guidance of YHLO’s corporate spirit and philosophy, they would be even more confident and capable in executing future market strategies. The representatives pledged to continue walking alongside YHLO to build the most trusted brand in the field of in vitro diagnostics.
On the following day, attendees visited YHLO’s newly completed headquarters building and held in-depth discussions with the company’s executives and core teams. During the session, regional distributor partners actively offered suggestions, providing valuable input on market strategy, product performance, and after-sales service, hoping YHLO will continue optimizing its products and services. The YHLO management team carefully listened to the partners’ feedback and suggestions, and committed to continuously investing in technology, improving product performance, and enhancing communication and cooperation with distributors to drive global success—together.
Attachments:
Previous Page
MORE NEWS
Add: Building 1, YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict, Longgang District, 518116 Shenzhen, P.R.China
